Epuja Spiritech Ltd vs Sheel Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 13, 2026

Key Highlights

The Latest Trading Price of Epuja Spiritech Ltd is ₹ 1.73 as of 13 Mar 15:30 . The P/E Ratio of Epuja Spiritech Ltd is 184 as of March 2025 .The P/E Ratio of Sheel Biotech Ltd is 0 as of March 2025 . The Market Cap of Epuja Spiritech Ltd is ₹ 30 crore as of March 2025 .The Market Cap of Sheel Biotech Ltd is ₹ 0 crore as of March 2025 . The revenue of Epuja Spiritech Ltd for the Dec '25 is ₹ 0.05 crore as compare to the Sep '25 revenue of ₹ 0.12 crore. This represent the decline of -58.33% The revenue of Sheel Biotech Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Epuja Spiritech Ltd for the Dec '25 is ₹ -2.78 crore as compare to the Sep '25 ebitda of ₹ -1.24 crore. This represent the growth of 124.19% The ebitda of Sheel Biotech Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Epuja Spiritech Ltd changed from ₹ -0.41 crore to ₹ -2.78 crore over 7 quarters. This represents a CAGR of 198.54% The net profit of Sheel Biotech Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Epuja Spiritech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sheel Biotech Ltd changed from 28.46 % on March 2022 to 14.05 % on March 2025 . This represents a CAGR of -16.18% over 4 years .

About Epuja Spiritech Ltd

Sagar Productions Limited (Formerly known as Kirti Finvest Limited) was incorporated in 1980, which later on was changed to its present name 'Sagar Productions Limited' in May 2010.
The Company is engaged in financing share trading and investments in India.

About Sheel Biotech Ltd

Sheel Biotech Limited was incorporated as a Private Company as 'Sheel Biotech Private Limited' dated November 26, 1991, with the Registrar of Companies, Delhi & Haryana.
Further, Company was converted into a Public Limited Company w.e.f.
April 02, 1992. The Company was founded by Dr. Satya Narayan Chandak in 1991.
Thereafter, through his vision he led the stone of Tissue Culture lab wherein for advancement of lab he deputed two of his scientists to Netherlands for training to expand the business ventured in domestic market too and then added greenhouse division to promote protected cultivation.
The Company started the Import division in 2019 and importing tulip, glad, lilium, orchids and alstromeria.

FAQs for the comparison of Epuja Spiritech Ltd and Sheel Biotech Ltd

Which company has a larger market capitalization, Epuja Spiritech Ltd or Sheel Biotech Ltd?

Market cap of Epuja Spiritech Ltd is 14 Cr while Market cap of Sheel Biotech Ltd is 111 Cr

What are the key factors driving the stock performance of Epuja Spiritech Ltd and Sheel Biotech Ltd?

The stock performance of Epuja Spiritech Ltd and Sheel Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Epuja Spiritech Ltd and Sheel Biotech Ltd?

As of March 13, 2026, the Epuja Spiritech Ltd stock price is INR ₹1.73. On the other hand, Sheel Biotech Ltd stock price is INR ₹54.8.

How do dividend payouts of Epuja Spiritech Ltd and Sheel Biotech Ltd compare?

To compare the dividend payouts of Epuja Spiritech Ltd and Sheel Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.